July 29, 2022
RFA-DA-23-051 - HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
This Notice announces the participation of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in RFA-DA-23-051 “HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)”, effective immediately.
The following sections of RFA-DA-23-051 have been modified (changes shown in bold italics) to reflect the participation of NICHD in this Funding Opportunity Announcement (FOA):
Part 1. Overview Information
Components of Participating Organizations
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Center for Complementary and Integrative Health (NCCIH)
National Cancer Institute (NCI)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Assistance Listing Number(s)
93.279, 93.242, 93.393, 93.213, 93.865
Part 2. Full Text of Announcement
Section VII. Agency Contacts
Scientific/Research Contact(s)
Michele Walsh, MD MSc
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-402-7886
Email: [email protected]
Financial/Grants Management Contact(s)
Margaret Young
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-642-4552
Email: [email protected]
Michele Walsh, MD MSc
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-402-7886
Email: [email protected]